COVID-19 impacts on the breast cancer care pathway among systemically marginalized communities in Ontario
Lofters AK, Premranjith P, Gayowksy A, Khalil I, Covelli AM, Daniel JM. Cancer Causes Control. 2025; Sep 24 [Epub ahead of print].
Background — Colon Cancer Check (CCC), Ontario's organized colorectal cancer (CRC) screening program, uses guaiac fecal occult blood testing (gFOBT). To reduce CRC-related mortality, persons with a positive gFOBT must have colonoscopy. We identified factors associated with failure to have colonoscopy within 6 months of a positive gFOBT.
Methods — Population-based, retrospective cohort analysis of CCC participants with positive gFOBT (April 2008 to December 2009) using health administrative data. Patient, physician and healthcare utilization factors associated with a lack of follow-up colonoscopy were identified using descriptive and multivariate analyses.
Results — There were 21,839 participants with a positive gFOBT; 14,091 (64%) had colonoscopy within 6 months. The strongest factors associated with failure to follow-up were recent colonoscopy (in 2 years prior vs. >10 years or never, OR: 4.31, 95% C.I.: 3.82, 4.86), as well as repeat gFOBT (OR: 6.08, 95% C.I.: 5.46, 6.78) and hospital admission (OR: 4.35, 95% C.I.: 3.57, 5.26) in the follow-up period.
Conclusion — In the first 18 months of the CCC Program, 1/3 of those with a positive gFOBT did not have colonoscopy within 6 months. Identification of potentially modifiable factors associated with failure to follow up lay the groundwork for interventions to address this critical quality gap.
Correia A, Rabeneck L, Baxter NN, Paszat LF, Sutradhar R, Yun L, Tinmouth J. Prev Med. 2015; 76:115-22. Epub 2015 Apr 17.
The ICES website uses cookies. If that’s okay with you, keep on browsing, or learn more about our Privacy Policy.